<VariationArchive VariationID="5512" VariationName="NM_014363.6(SACS):c.8844del (p.Ile2949fs)" VariationType="Deletion" Accession="VCV000005512" Version="29" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-07-29" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20551" VariationID="5512">
      <GeneList>
        <Gene Symbol="SACS" FullName="sacsin molecular chaperone" GeneID="26278" HGNC_ID="HGNC:10519" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23328830" stop="23433702" display_start="23328830" display_stop="23433702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23902964" stop="24007840" display_start="23902964" display_stop="24007840" Strand="-" />
          </Location>
          <OMIM>604490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014363.6(SACS):c.8844del (p.Ile2949fs)</Name>
      <CanonicalSPDI>NC_000013.11:23335031:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q12.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23335032" stop="23335032" display_start="23335032" display_stop="23335032" variantLength="1" positionVCF="23335031" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23909171" stop="23909171" display_start="23909171" display_stop="23909171" variantLength="1" positionVCF="23909170" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I2802fs</ProteinChange>
      <ProteinChange>I2949fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.23909171del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.23909171del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.23335032del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.23335032del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012342.1" sequenceAccession="NG_012342" sequenceVersion="1" change="g.103671del">
            <Expression>NG_012342.1:g.103671del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278055.2" sequenceAccession="NM_001278055" sequenceVersion="2" change="c.8403del">
            <Expression>NM_001278055.2:c.8403del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264984.1" sequenceAccession="NP_001264984" sequenceVersion="1" change="p.Ile2802fs">
            <Expression>NP_001264984.1:p.Ile2802fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.6" sequenceAccession="NM_014363" sequenceVersion="6" change="c.8844del" MANESelect="true">
            <Expression>NM_014363.6:c.8844del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055178.3" sequenceAccession="NP_055178" sequenceVersion="3" change="p.Ile2949fs">
            <Expression>NP_055178.3:p.Ile2949fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604490.0001" DB="OMIM" />
        <XRef Type="rs" ID="281865117" DB="dbSNP" />
        <XRef ID="CA340432" DB="ClinGen" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00005" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00006" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014363.6(SACS):c.8844del (p.Ile2949fs) AND Charlevoix-Saguenay spastic ataxia" Accession="RCV000005847" Version="20">
        <ClassifiedConditionList TraitSetID="1544">
          <ClassifiedCondition DB="MedGen" ID="C1849140">Charlevoix-Saguenay spastic ataxia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-18" SubmissionCount="9">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.8844del (p.Ile2949fs) AND not provided" Accession="RCV000338359" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.8844del (p.Ile2949fs) AND Spastic paraplegia" Accession="RCV000460039" Version="9">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.8844del (p.Ile2949fs) AND Hereditary spastic paraplegia" Accession="RCV001847583" Version="3">
        <ClassifiedConditionList TraitSetID="8750">
          <ClassifiedCondition DB="MedGen" ID="C0037773">Hereditary spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-18" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10610707</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10655055</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11788093</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14718706</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22307627</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23250129</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28658401</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301432</ID>
          <ID Source="BookShelf">NBK1255</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1544" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charlevoix-Saguenay spastic ataxia</ElementValue>
                <XRef ID="MONDO:0010041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPAX6</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARSACS</ElementValue>
                <XRef ID="NBK1255" DB="GeneReviews" />
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SACS</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is clinically characterized by a progressive cerebellar ataxia, peripheral neuropathy, and spasticity. Disease onset of classic ARSACS is often in early childhood, leading to delayed walking because of gait unsteadiness in very young toddlers, while an increasing number of individuals with disease onset in teenage or early-adult years are now being described. Typically the ataxia is followed by lower-limb spasticity and later by peripheral neuropathy – although pronounced peripheral neuropathy has been observed as a first sign of ARSACS. Oculomotor disturbances, dysarthria, and upper-limb ataxia develop with slower progression than the other findings. Brain imaging demonstrates atrophy of the superior vermis and the cerebellar hemisphere with additional findings on MRI, such as linear hypointensities in the pons and hyperintense rims around the thalami. Many affected individuals (though not all) have yellow streaks of hypermyelinated fibers radiating from the edges of the optic disc noted on ophthalmologic exam, and thickened retinal fibers can be demonstrated by optical coherence tomography. Mild intellectual disability, hearing loss, and urinary urgency and incontinence have been reported in some individuals.</Attribute>
                <XRef ID="NBK1255" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4910" />
                <XRef ID="4910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301432</ID>
                <ID Source="BookShelf">NBK1255</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="98" DB="Orphanet" />
              <XRef ID="C1849140" DB="MedGen" />
              <XRef ID="MONDO:0010041" DB="MONDO" />
              <XRef Type="MIM" ID="270550" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14327" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia</ElementValue>
                <XRef ID="Hereditary+spastic+paraplegia/3383" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019064" DB="MONDO" />
                <XRef ID="39912006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraparesis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500218" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592992" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508756" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6637" />
                <XRef ID="6637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301682</ID>
                <ID Source="BookShelf">NBK1509</ID>
              </Citation>
              <XRef ID="685" DB="Orphanet" />
              <XRef ID="C0037773" DB="MedGen" />
              <XRef ID="MONDO:0019064" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS303350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26029" SubmissionDate="2014-02-21" DateLastUpdated="2014-03-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604490.0001_SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" title="SACS, 1-BP DEL, 6594T _SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" />
        <ClinVarAccession Accession="SCV000026029" DateUpdated="2014-03-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-01-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Among patients with spastic ataxia of the Charlevoix-Saguenay type (ARSACS; 270550), 2 ancestral haplotypes had been identified (Engert et al., 1999). Engert et al. (2000) sequenced the DNA from ARSACS patients and controls and found a single-base deletion of a T at position 6594 on all copies of the major ancestral haplotype examined. This mutation resulted in a frameshift and introduction of a stop codon.</Attribute>
              <Citation>
                <ID Source="PubMed">10610707</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10655055</ID>
              </Citation>
              <XRef DB="OMIM" ID="270550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Criscuolo et al. (2004) stated that the 6594delT mutation accounts for approximately 94% of the disease alleles among individuals in the French Canadian population with ARSACS.</Attribute>
              <Citation>
                <ID Source="PubMed">14718706</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <Name>SACS, 1-BP DEL, 6594T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 6594T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604490.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354507" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="8|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194052" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000678179" DateChanged="2020-07-02" Version="2">
            <Comment Type="MergeComment">SCV000678179 was merged into SCV001194052 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10655055</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11788093</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23250129</ID>
          </Citation>
          <Comment>NM_014363.4(SACS):c.8844delT(I2949Ffs*4, aka 6594delT) is classified as pathogenic in the context of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Sources cited for classification include the following: PMID 10655055, 11788093 and 23250129. Classification of NM_014363.4(SACS):c.8844delT(I2949Ffs*4, aka 6594delT) is based on the following criteria: The variant causes a premature termination codon that is not expected to be targeted by nonsense-mediated mRNA decay; however literature evidence supports pathogenicity. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="T" referenceAllele="TA" start="23909170" stop="23909171" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3971049" SubmissionDate="2021-11-24" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="NM_014363.6:c.8844del|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002027632" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.8844del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10716879</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5434379" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_014363.6:c.8844del|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002782621" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.8844del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3962820" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="a18599e0c632c2eadecffb7dbb800fe616bf570ce799375950ee83506320fb2d|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019979" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.8844del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1065881" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="88193|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000552973" DateUpdated="2024-02-20" DateCreated="2017-04-17" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10655055</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11788093</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10655055</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11788093</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22307627</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile2949Phefs*4) in the SACS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1631 amino acid(s) of the SACS protein. This variant is present in population databases (rs281865117, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with spastic ataxia of Charlevoix-Saguenay (ARSACS) (PMID: 10655055, 11788093). It is commonly reported in individuals of Quebec ancestry (PMID: 10655055, 11788093). This variant is also known as g.6594delT. ClinVar contains an entry for this variant (Variation ID: 5512). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects SACS function (PMID: 22307627). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.23909171del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643261" SubmissionDate="2017-11-28" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDX:741760|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000329911" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.8844delT pathogenic variant in the SACS gene has been reported previously in association with autosomalrecessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and is a founder mutation in the French Canadianpopulation (Engert et al., 2000; Thiffault et al., 2013; Duquette et al., 2013). The c.8844delT variant causes aframeshift starting with codon Isoleucine 2949, changes this amino acid to a Phenylalanine residue, and creates apremature Stop codon at position 4 of the new reading frame, denoted p.Ile2949PhefsX4. This variant is predicted tocause loss of normal protein function through protein truncation. The c.8844delT variant was not observed inapproximately 6500 individuals of European and African American ancestry in the NHLBI Exome SequencingProject, indicating it is not a common benign variant in these populations. We interpret c.8844delT as a pathogenicvariant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.4:c.8844delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794800" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_014363.4:c.8844delT|MedGen:C1849140" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000918180" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28658401</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23250129</ID>
          </Citation>
          <Comment>Variant summary: The SACS c.8844delT (p.Ile2949PhefsX4) variant results in a premature termination codon, predicted to cause a truncated or absent SACS protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The lack of the of sacsin protein was confirmed by Western blott performed on immortalized lymphoblasts extracted from homozygous carriers. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g.c.11374C&gt;T/p.Arg3792X). This variant was found in 17/276618 control chromosomes at a frequency of 0.0000615, which does not exceed the estimated maximal expected allele frequency of a pathogenic SACS variant (0.0079057). This variant appears to be a founder mutation in French-Canadian ARSACS patients (Thiffaul_2013). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.4:c.8844delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Spastic ataxia Charlevoix-Saguenay type</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1849140" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4083847" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_014363.6:c.8844del|Charlevoix-Saguenay type spastic ataxia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002086206" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.8844del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Charlevoix-Saguenay type spastic ataxia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4117876" SubmissionDate="2022-03-15" DateLastUpdated="2022-03-19" DateCreated="2022-03-19">
        <ClinVarSubmissionID localKey="2022-01750|MONDO:0019064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002105107" DateUpdated="2022-03-19" DateCreated="2022-03-19" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.5:c.8844delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019064" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11183483</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="91168" SubmissionDate="2021-02-08" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_014363.5:c.8844delT|OMIM:270550" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000054639" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11788093</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.5:c.8844delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1849140" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">20301432</ID>
          <ID Source="BookShelf">NBK1255</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB9047487</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855491" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_014363.6:c.8844del|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004209930" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.8844del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1794800" TraitType="Disease" MappingType="Name" MappingValue="Spastic ataxia Charlevoix-Saguenay type" MappingRef="Preferred">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354507" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1065881" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4083847" TraitType="Disease" MappingType="Name" MappingValue="Charlevoix-Saguenay type spastic ataxia" MappingRef="Preferred">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7855491" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26029" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" MappingRef="Preferred">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5434379" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4117876" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019064" MappingRef="MONDO">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="91168" TraitType="Disease" MappingType="XRef" MappingValue="C1849140" MappingRef="MedGen">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3962820" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643261" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3971049" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

